ROSENBLUM MARK J (Exec VP Finance, Interim CFO) received a stock award from DECOY THERAPEUTICS INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 11/5/2021ACC: 0001615219-21-000095
Officer· Exec VP Finance, Interim CFO
Since Sep 2019
+7.79K
Net shares
Net buyer
$5.6K
Total acquired
0
Open market trades
0B · 0S
1
Total transactions
7.79K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+7.79K
Price / share
$0.72
Trade value
$5.59K
% of position
29.6%
11/3/2021
26.29K→34.07K
Total
Net shares
+7.79K
Net value
$5.59K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 11/3/2021 | A · Award | +7.79K | $0.72 | $5.59K | 29.6% | 26.29K | 34.07K |
| Total | +7.79K | $5.59K | ||||||
Derivative Transactions0
No derivative transactions reported